03Jul
Committed to Clarity: FDA’s Dedication to Transparency with the End of ASR
On June 21, the Food and Drug Administration (FDA) released a report titled “Statement on agency’s efforts to increase transparency in medical device reporting.” This report describes updates to FDA’s Medical Device Reporting (MDR) Program, namely...
By:
Morrison & Foerster LLP
Related
The new National Security and Investment Bill, which aims to provide the Government with the necessa...
Read More >
The issue of willfulness is very important in FLSA cases because such a finding extends the statute ...
Read More >
Colorado has become the latest jurisdiction to join the “ban the box” movement. The Colorado Chanc...
Read More >
In 2020, we will start to see private UK companies including the new corporate governance and report...
Read More >
There is debate among employers as to whether or not being morbidly obese is considered an ADA-cover...
Read More >
EU, UK Competition, State Aid and Public Procurement Law During COVID-19 - While not the most impor...
Read More >